Soleno Therapeutics Inc. (NASDAQ:SLNO) traded today at a new 52-week low of $1.15. This new low was reached on below average trading volume as 1.1 million shares traded hands, while the average 30-day volume is approximately 2.7 million shares.
Soleno Therapeutics Inc. share prices have moved between a 52-week high of $4.39 and the current low of $1.15 and are currently at $1.22 per share.
Soleno Therapeutics Inc is a healthcare service provider. It develops and commercializes diagnostics, devices, and therapeutics addressing unmet medical needs. It has a range of commercial products based on its proprietary technologies, including those which utilize precision metering of gas flow. Its product candidates comprise of Serenz Allergy Relief, or Serenz, which is a proprietary handheld device that delivers non-inhaled CO2 topically to the nasal mucosa.
Soleno Therapeutics Inc. (NASDAQ:SLNO) has potential upside of 24.3% based on a current price of $1.22 and analysts’ consensus price target of $1.52.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer